Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 13.03 Million USD | 304.36% |
| 2021 | 3.22 Million USD | -55.22% |
| 2020 | 7.2 Million USD | -54.96% |
| 2019 | 15.98 Million USD | 9.89% |
| 2018 | 14.54 Million USD | 214.94% |
| 2017 | 4.61 Million USD | -11.93% |
| 2016 | 5.24 Million USD | -71.48% |
| 2015 | 18.39 Million USD | 3593.38% |
| 2014 | 498 Thousand USD | -24.32% |
| 2013 | 658 Thousand USD | 64.5% |
| 2012 | 400 Thousand USD | 300.0% |
| 2011 | 100 Thousand USD | 525.0% |
| 2010 | 16 Thousand USD | -99.87% |
| 2009 | 12.39 Million USD | -5.14% |
| 2008 | 13.07 Million USD | -60.3% |
| 2007 | 32.92 Million USD | 47.89% |
| 2006 | 22.26 Million USD | 2.33% |
| 2005 | 21.75 Million USD | 46.14% |
| 2004 | 14.88 Million USD | -9.92% |
| 2003 | 16.52 Million USD | 17.22% |
| 2002 | 14.1 Million USD | -34.74% |
| 2001 | 21.6 Million USD | -43.45% |
| 2000 | 38.2 Million USD | 44.51% |
| 1999 | 26.43 Million USD | -8.83% |
| 1998 | 29 Million USD | -30.12% |
| 1997 | 41.5 Million USD | -27.7% |
| 1996 | 57.4 Million USD | -7.42% |
| 1995 | 62 Million USD | 39.01% |
| 1994 | 44.6 Million USD | 17.31% |
| 1993 | 38.02 Million USD | -11.13% |
| 1992 | 42.78 Million USD | 1.47% |
| 1991 | 42.16 Million USD | 2.85% |
| 1990 | 40.99 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | 4.91 Million USD | -9.96% |
| 2023 Q2 | 6.38 Million USD | 29.97% |
| 2023 Q3 | 3.53 Million USD | -44.62% |
| 2022 FY | 13.03 Million USD | 304.36% |
| 2022 Q3 | 2.82 Million USD | -21.64% |
| 2022 Q4 | 5.45 Million USD | 93.19% |
| 2022 Q2 | 3.6 Million USD | 215.09% |
| 2022 Q1 | 1.14 Million USD | -40.87% |
| 2021 Q4 | 1.93 Million USD | 91.59% |
| 2021 FY | 3.22 Million USD | -55.22% |
| 2021 Q3 | 1.01 Million USD | 8.76% |
| 2021 Q1 | -650.69 Thousand USD | -148.58% |
| 2021 Q2 | 928.84 Thousand USD | 242.75% |
| 2020 FY | 7.2 Million USD | -54.96% |
| 2020 Q1 | 1.84 Million USD | -35.36% |
| 2020 Q2 | 2.06 Million USD | 12.35% |
| 2020 Q3 | 1.95 Million USD | -5.72% |
| 2020 Q4 | 1.33 Million USD | -31.34% |
| 2019 Q1 | 5.19 Million USD | 12.46% |
| 2019 Q2 | 4.06 Million USD | -21.76% |
| 2019 Q3 | 3.88 Million USD | -4.31% |
| 2019 Q4 | 2.84 Million USD | -26.68% |
| 2019 FY | 15.98 Million USD | 9.89% |
| 2018 FY | 14.54 Million USD | 214.94% |
| 2018 Q1 | 1.6 Million USD | 22.55% |
| 2018 Q4 | 4.61 Million USD | -8.4% |
| 2018 Q3 | 5.03 Million USD | 53.06% |
| 2018 Q2 | 3.29 Million USD | 105.55% |
| 2017 Q2 | 898.73 Thousand USD | -23.58% |
| 2017 Q3 | 1.41 Million USD | 57.36% |
| 2017 Q4 | 1.3 Million USD | -7.58% |
| 2017 Q1 | 1.17 Million USD | 5108.19% |
| 2017 FY | 4.61 Million USD | -11.93% |
| 2016 FY | 5.24 Million USD | -71.48% |
| 2016 Q1 | 1.87 Million USD | 117.85% |
| 2016 Q2 | 3.05 Million USD | 62.53% |
| 2016 Q3 | 290 Thousand USD | -90.5% |
| 2016 Q4 | 22.58 Thousand USD | -92.21% |
| 2015 Q2 | 108 Thousand USD | -34.15% |
| 2015 Q3 | 116 Thousand USD | 7.41% |
| 2015 FY | 18.39 Million USD | 3593.38% |
| 2015 Q1 | 164 Thousand USD | 74.47% |
| 2015 Q4 | -10.52 Million USD | -9176.13% |
| 2014 Q2 | 64 Thousand USD | -20.99% |
| 2014 Q1 | 81 Thousand USD | 44.64% |
| 2014 Q4 | 94 Thousand USD | -46.59% |
| 2014 Q3 | 176 Thousand USD | 175.0% |
| 2014 FY | 498 Thousand USD | -24.32% |
| 2013 Q4 | 56 Thousand USD | -77.69% |
| 2013 Q3 | 251 Thousand USD | -7.04% |
| 2013 Q2 | 270 Thousand USD | -1.82% |
| 2013 Q1 | 275 Thousand USD | 1000.0% |
| 2013 FY | 658 Thousand USD | 64.5% |
| 2012 Q1 | 25 Thousand USD | -34.21% |
| 2012 FY | 400 Thousand USD | 300.0% |
| 2012 Q2 | 25 Thousand USD | 0.0% |
| 2012 Q3 | 75 Thousand USD | 200.0% |
| 2012 Q4 | 25 Thousand USD | -66.67% |
| 2011 Q4 | 38 Thousand USD | 100.0% |
| 2011 FY | 100 Thousand USD | 525.0% |
| 2011 Q3 | 19 Thousand USD | 0.0% |
| 2011 Q2 | 19 Thousand USD | 100.39% |
| 2011 Q1 | -4.83 Million USD | -459.18% |
| 2010 Q1 | 3.12 Million USD | -38.37% |
| 2010 Q2 | 319 Thousand USD | -89.8% |
| 2010 Q3 | 3.18 Million USD | 897.81% |
| 2010 Q4 | 1.34 Million USD | -57.74% |
| 2010 FY | 16 Thousand USD | -99.87% |
| 2009 Q1 | 1.85 Million USD | -58.56% |
| 2009 Q4 | 5.07 Million USD | 62.72% |
| 2009 FY | 12.39 Million USD | -5.14% |
| 2009 Q2 | 1.08 Million USD | -41.62% |
| 2009 Q3 | 3.11 Million USD | 187.81% |
| 2008 Q1 | 7.38 Million USD | -27.24% |
| 2008 FY | 13.07 Million USD | -60.3% |
| 2008 Q3 | 2.01 Million USD | -57.5% |
| 2008 Q4 | 4.47 Million USD | 122.69% |
| 2008 Q2 | 4.72 Million USD | -35.94% |
| 2007 Q2 | 4.59 Million USD | -25.8% |
| 2007 Q1 | 6.19 Million USD | 41.58% |
| 2007 FY | 32.92 Million USD | 47.89% |
| 2007 Q4 | 10.14 Million USD | -6.06% |
| 2007 Q3 | 10.8 Million USD | 134.88% |
| 2006 Q2 | 6.57 Million USD | 8.64% |
| 2006 Q1 | 6.05 Million USD | -3.09% |
| 2006 FY | 22.26 Million USD | 2.33% |
| 2006 Q4 | 4.37 Million USD | -14.39% |
| 2006 Q3 | 5.11 Million USD | -22.25% |
| 2005 Q2 | 3.05 Million USD | -14.17% |
| 2005 FY | 21.75 Million USD | 46.14% |
| 2005 Q1 | 3.55 Million USD | 22.49% |
| 2005 Q4 | 6.24 Million USD | -2.5% |
| 2005 Q3 | 6.4 Million USD | 109.9% |
| 2004 Q2 | 3.44 Million USD | -44.11% |
| 2004 Q3 | 4.98 Million USD | 44.96% |
| 2004 FY | 14.88 Million USD | -9.92% |
| 2004 Q4 | 2.9 Million USD | -41.8% |
| 2004 Q1 | 6.15 Million USD | 87.94% |
| 2003 Q4 | 3.27 Million USD | 2.06% |
| 2003 Q2 | 3.88 Million USD | -2.92% |
| 2003 Q1 | 4 Million USD | 8.13% |
| 2003 FY | 16.52 Million USD | 17.22% |
| 2003 Q3 | 3.21 Million USD | -17.37% |
| 2002 Q4 | 3.7 Million USD | 38.36% |
| 2002 FY | 14.1 Million USD | -34.74% |
| 2002 Q3 | 2.67 Million USD | -28.13% |
| 2002 Q2 | 3.72 Million USD | -46.59% |
| 2002 Q1 | 6.96 Million USD | 194.17% |
| 2001 Q2 | 7.88 Million USD | 36.56% |
| 2001 Q4 | 2.36 Million USD | -45.9% |
| 2001 Q3 | 4.37 Million USD | -44.49% |
| 2001 Q1 | 5.77 Million USD | -49.63% |
| 2001 FY | 21.6 Million USD | -43.45% |
| 2000 Q3 | 13.27 Million USD | 72.77% |
| 2000 FY | 38.2 Million USD | 44.51% |
| 2000 Q4 | 11.46 Million USD | -13.62% |
| 2000 Q1 | 8.53 Million USD | 31.35% |
| 2000 Q2 | 7.68 Million USD | -10.0% |
| 1999 Q1 | 6 Million USD | -7.69% |
| 1999 FY | 26.43 Million USD | -8.83% |
| 1999 Q4 | 6.5 Million USD | 38.3% |
| 1999 Q3 | 4.7 Million USD | -29.85% |
| 1999 Q2 | 6.7 Million USD | 11.67% |
| 1998 Q1 | 8.4 Million USD | -31.71% |
| 1998 Q4 | 6.5 Million USD | -35.0% |
| 1998 Q3 | 10 Million USD | 53.85% |
| 1998 Q2 | 6.5 Million USD | -22.62% |
| 1998 FY | 29 Million USD | -30.12% |
| 1997 Q2 | 9.1 Million USD | -31.58% |
| 1997 Q3 | 11.7 Million USD | 28.57% |
| 1997 Q4 | 12.3 Million USD | 5.13% |
| 1997 FY | 41.5 Million USD | -27.7% |
| 1997 Q1 | 13.3 Million USD | 1.53% |
| 1996 FY | 57.4 Million USD | -7.42% |
| 1996 Q3 | 12.8 Million USD | -30.05% |
| 1996 Q4 | 13.1 Million USD | 2.34% |
| 1996 Q1 | 17.5 Million USD | 1.74% |
| 1996 Q2 | 18.3 Million USD | 4.57% |
| 1995 FY | 62 Million USD | 39.01% |
| 1995 Q4 | 17.2 Million USD | 20.28% |
| 1995 Q2 | 13.1 Million USD | 12.93% |
| 1995 Q3 | 14.3 Million USD | 9.16% |
| 1995 Q1 | 11.6 Million USD | 1.75% |
| 1994 FY | 44.6 Million USD | 17.31% |
| 1994 Q4 | 11.4 Million USD | -1.72% |
| 1994 Q3 | 11.6 Million USD | 16.0% |
| 1994 Q2 | 10 Million USD | 0.0% |
| 1993 FY | 38.02 Million USD | -11.13% |
| 1992 FY | 42.78 Million USD | 1.47% |
| 1991 FY | 42.16 Million USD | 2.85% |
| 1990 FY | 40.99 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -1327.839% |
| Arrayit Corporation | 4.37 Million USD | -197.813% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 49.586% |
| Bioqual, Inc. | 58.59 Million USD | 77.751% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 14.774% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.823% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -104.771% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -1139.663% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 67.583% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -2813.118% |
| InVitro International | 792.62 Thousand USD | -1544.677% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -17.116% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -80.451% |
| NovelStem International Corp. | 12 Thousand USD | -108534.767% |
| Optigenex Inc. | 465.97 Thousand USD | -2697.642% |
| PharmChem, Inc. | 6.01 Million USD | -116.821% |
| Proteome Sciences plc | 6.4 Million USD | -103.67% |
| Response Genetics, Inc | 18.04 Million USD | 27.737% |
| RushNet, Inc. | 1.78 Million USD | -629.141% |
| ScreenPro Security Inc. | 1.91 Million USD | -581.059% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -243.502% |
| Todos Medical Ltd. | 7.69 Million USD | -69.411% |